World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
104
Citations
33695
World Ranking
470
National Ranking
264

Gary L. Johnson publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Gary L. Johnson sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 338 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Gary L. Johnson D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Gary L. Johnson sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 104 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Gary L. Johnson is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans across multiple fields within medicine and biochemistry, genetics, and molecular biology, with a significant focus on molecular biology, oncology, and neurology.

Their scholarly output includes 107 publications related to medicine and 93 in biochemistry, genetics, and molecular biology. Within these, notable subfields of study are molecular biology (61 publications), oncology (28), neurology (22), cancer research (17), and organic chemistry (14).

Johnson's main research topics encompass:

  • Melanoma and MAPK Pathways
  • Neurofibromatosis and Schwannoma Cases
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Phagocytosis and Immune Regulation
  • Neuroblastoma Research and Treatments
  • Cancer Mechanisms and Therapy

Frequent coauthors in Johnson's collaborative work include Michael P. East, Steven P. Angus, Christopher R. M. Asquith, Timothy J. Stuhlmiller, and Shawn M. Gomez.

Publications have been distributed across various venues, with the highest number appearing in UNC Libraries (54), followed by Cancer Research (10), bioRxiv (Cold Spring Harbor Laboratory) (8), Neuro-Oncology (3), and the Journal of Biological Chemistry (2).

Selected recent papers illustrate the focus of Johnson's research:

  • FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease, 2020, Journal of Clinical Investigation
  • Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial, 2021, Nature Medicine
  • New strategies for targeting kinase networks in cancer, 2021, Journal of Biological Chemistry
  • Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK, 2021, PLoS ONE
  • Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy, 2020, JCI Insight

Best Publications

  • Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

    James S. Duncan;Martin C. Whittle;Kazuhiro Nakamura;Amy N. Abell

  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

    Daniel R. Ambruso;Cindy Knall;Amy N. Abell;Julie Panepinto

  • Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.

    Nancy Lassignal Johnson;Anne M. Gardner;Katrina M. Diener;Carol A. Lange-Carter

  • Sequential protein kinase reactions controlling cell growth and differentiation

    Gary L. Johnson;Richard R. Vaillancourt

  • Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.

    Toshiaki Yujiri;Susan Sather;Gary R. Fanger;Gary L. Johnson

  • MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

    Gary R Fanger;Pär Gerwins;Christian Widmann;Matthew B Jarpe

  • Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases

    Cindy Knall;G. Scott Worthen;G. Scott Worthen;Gary L. Johnson

  • Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.

    B E Wadzinski;W H Wheat;S Jaspers;L F Peruski

  • Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model

    Robert S. Stearman;Lori Dwyer-Nield;Laura Zerbe;Stacy A. Blaine

  • Unexplored therapeutic opportunities in the human genome.

    Tudor I. Oprea;Cristian G. Bologa;Søren Brunak;Allen Campbell

  • Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.

    J A Nick;N J Avdi;S K Young;C Knall

  • Role of mitogen-activated protein kinase kinase kinases in signal integration.

    B D Cuevas;A N Abell;G L Johnson

  • Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils

    Jerry A. Nick;Jerry A. Nick;Natalie J. Avdi;Scott K. Young;Lisa A. Lehman

  • Cloning of a Novel Mitogen-activated Protein Kinase Kinase Kinase, MEKK4, That Selectively Regulates the c-Jun Amino Terminal Kinase Pathway

    Pär Gerwins;Jonathan L. Blank;Gary L. Johnson

  • Structural and evolutionary division of phosphotyrosine binding (PTB) domains.

    Mark T. Uhlik;Brenda Temple;Sompop Bencharit;Adam J. Kimple

  • Involvement of Ras and Raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase.

    S. Winitz;M. Russell;Nan-Xin Qian;A. Gardner

  • Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

    Timothy J. Stuhlmiller;Samantha M. Miller;Jon S. Zawistowski;Kazuhiro Nakamura

  • MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation

    Toshiaki Yujiri;Margaret Ware;Margaret Ware;Christian Widmann;Christian Widmann;Ryan Oyer

  • MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts.

    S K Gupta;C Gallego;G L Johnson;L E Heasley

  • CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis

    Jon S. Zawistowski;Lisa Stalheim;Mark T. Uhlik;Amy N. Abell

Frequent Co-Authors

Lee M. Graves
Lee M. Graves University of North Carolina at Chapel Hill
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Lynn E. Heasley
Lynn E. Heasley University of Colorado Anschutz Medical Campus
H. Shelton Earp
H. Shelton Earp University of North Carolina at Chapel Hill
Frank B. Furnari
Frank B. Furnari University of California, San Diego
Joel S. Parker
Joel S. Parker University of North Carolina at Chapel Hill
Naohiro Terada
Naohiro Terada University of Florida
Michael E. Berens
Michael E. Berens Translational Genomics Research Institute
Stephen V. Frye
Stephen V. Frye University of North Carolina at Chapel Hill
Marsha Rich Rosner
Marsha Rich Rosner University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology often sparks interest in other dynamic fields. If you’re looking for diverse academic routes, there are plenty of online programs that can complement your passion for science. For example, those interested in environmental sciences or structural biology may benefit from an online architecture degree, which blends creativity and problem-solving with scientific principles.

Analytical thinkers might consider an online math bachelor's degree to strengthen quantitative skills relevant to bioinformatics or research data analysis. For students creatively inclined, a graphic design online degree can open career paths in scientific illustration, medical imaging, and science communication.

Budget-conscious learners should also explore online interdisciplinary studies tuition costs to find flexible, affordable options that merge molecular biology with other interests. Each of these online degrees offers valuable skills to broaden your career pathways, making it easier than ever to tailor your education to your goals.

Best Scientists Citing Gary L. Johnson

Trending Scientists

Recently Published Articles